Skip to content

Agilon Health AGL Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

Astrana Health logo
Astrana HealthASTH

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's equity method investments (note 11)?
Agilon Health (AGL) reported equity method investments (note 11) of $72.15M in Q1 2026.
How has Agilon Health's equity method investments (note 11) changed year-over-year?
Agilon Health's equity method investments (note 11) decreased by 1.2% year-over-year, from $73.04M to $72.15M.
What is the long-term trend for Agilon Health's equity method investments (note 11)?
Over 3 years (2022 to 2025), Agilon Health's equity method investments (note 11) has grown at a 51.0% compound annual growth rate (CAGR), from $17.35M to $59.79M.